Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Guzman

Showing results (191-200 of 213) with videos related to

Pageof 22
Sort By:
Cancer Cell|March 31, 2015
Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivoDmitry Borkin, Shihan He, Hongzhi Miao, et al.
Cell Reports|February 10, 2021
Clonal hematopoiesis before, during, and after human spaceflightNuria Mencia-Trinchant, Matthew J MacKay, Christopher Chin, et al.
Cell Reports|November 26, 2020
Clonal Hematopoiesis Before, During, and After Human SpaceflightNuria Mencia-Trinchant, Matthew J MacKay, Christopher Chin, et al.
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Ebiomedicine|July 19, 2016
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersAnuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Ebiomedicine|November 7, 2017
Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131]Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Nature Chemical Biology|June 22, 2021
Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domainShirish Shukla, Weijiang Ying, Felicia Gray, et al.
Hemasphere|December 29, 2021
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working PartyJesse M Tettero, Sylvie Freeman, Veit Buecklein, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Pageof 22

Showing results (191-200 of 213) with videos related to

Sort By:
Pageof 22
Cancer Cell|March 31, 2015
Pharmacologic inhibition of the Menin-MLL interaction blocks progression of MLL leukemia in vivoDmitry Borkin, Shihan He, Hongzhi Miao, et al.
Cell Reports|February 10, 2021
Clonal hematopoiesis before, during, and after human spaceflightNuria Mencia-Trinchant, Matthew J MacKay, Christopher Chin, et al.
Cell Reports|November 26, 2020
Clonal Hematopoiesis Before, During, and After Human SpaceflightNuria Mencia-Trinchant, Matthew J MacKay, Christopher Chin, et al.
Cancer Discovery|April 15, 2017
Epigenetic Identity in AML Depends on Disruption of Nonpromoter Regulatory Elements and Is Affected by Antagonistic Effects of Mutations in Epigenetic ModifiersJacob L Glass, Duane Hassane, Bas J Wouters, et al.
Ebiomedicine|July 19, 2016
Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven CancersAnuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Ebiomedicine|November 7, 2017
Corrigendum to: "Small Molecule Inhibitor of CBFβ-RUNX Binding for RUNX Transcription Factor Driven Cancers" [EBioMedicine 8 (2016) 117-131]Anuradha Illendula, Jane Gilmour, Jolanta Grembecka, et al.
Nature Chemical Biology|June 22, 2021
Small-molecule inhibitors targeting Polycomb repressive complex 1 RING domainShirish Shukla, Weijiang Ying, Felicia Gray, et al.
Hemasphere|December 29, 2021
Technical Aspects of Flow Cytometry-based Measurable Residual Disease Quantification in Acute Myeloid Leukemia: Experience of the European LeukemiaNet MRD Working PartyJesse M Tettero, Sylvie Freeman, Veit Buecklein, et al.
Leukemia|May 15, 2015
Pharmacological targeting of miR-155 via the NEDD8-activating enzyme inhibitor MLN4924 (Pevonedistat) in FLT3-ITD acute myeloid leukemiaJ Khalife, H S Radomska, R Santhanam, et al.
Cancer Discovery|October 31, 2012
Integrative epigenomic analysis identifies biomarkers and therapeutic targets in adult B-acute lymphoblastic leukemiaHuimin Geng, Sarah Brennan, Thomas A Milne, et al.
Pageof 22